VA bill targets new mental health therapies for veterans

What does this do?

This bill would create the Office of Novel Therapeutics inside the Veterans Health Administration to set policies, safety standards, and training for new mental health treatments under FDA review. It would also launch a program to test these treatments in real VA settings and allow certain VA medical centers to become centers of excellence for research and training. A new advisory committee of veterans, family members, and health experts would give input on patient safety and access.

Who does it affect?

This bill primarily affects veterans with conditions like PTSD, depression, substance use disorders, and traumatic brain injury. It also affects VA clinicians and staff who would be trained and certified to deliver these treatments.

Why does it matter?

If these treatments receive federal approval, the VA would already have the systems and trained staff in place to offer them to veterans. Without this preparation, there could be delays in veterans being able to access newly approved therapies.

Where does it stand?